- Home
- TPCS vs APLT Comparison
TPCS vs APLT Comparison
Compare TPCS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- APLT
- Stock Information
- Founded
- TPCS 1956
- APLT 2016
- Country
- TPCS United States
- APLT United States
- Employees
- TPCS N/A
- APLT N/A
- Industry
- TPCS Metal Fabrications
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- APLT Health Care
- Exchange
- TPCS Nasdaq
- APLT Nasdaq
- Market Cap
- TPCS 42.6M
- APLT 37.5M
- IPO Year
- TPCS N/A
- APLT 2019
- Fundamental
- Price
- TPCS $3.75
- APLT $0.35
- Analyst Decision
- TPCS
- APLT Buy
- Analyst Count
- TPCS 0
- APLT 7
- Target Price
- TPCS N/A
- APLT $6.10
- AVG Volume (30 Days)
- TPCS 68.2K
- APLT 2.9M
- Earning Date
- TPCS 04-08-2025
- APLT 05-13-2025
- Dividend Yield
- TPCS N/A
- APLT N/A
- EPS Growth
- TPCS N/A
- APLT N/A
- EPS
- TPCS N/A
- APLT N/A
- Revenue
- TPCS $33,154,058.00
- APLT $265,000.00
- Revenue This Year
- TPCS N/A
- APLT $1,768.13
- Revenue Next Year
- TPCS N/A
- APLT $332.85
- P/E Ratio
- TPCS N/A
- APLT N/A
- Revenue Growth
- TPCS 8.71
- APLT N/A
- 52 Week Low
- TPCS $2.05
- APLT $0.30
- 52 Week High
- TPCS $4.42
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- TPCS 59.62
- APLT 41.58
- Support Level
- TPCS $3.75
- APLT $0.35
- Resistance Level
- TPCS $4.00
- APLT $0.40
- Average True Range (ATR)
- TPCS 0.28
- APLT 0.06
- MACD
- TPCS -0.04
- APLT -0.01
- Stochastic Oscillator
- TPCS 46.83
- APLT 1.17
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.